Main Street Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51K Hold
132
0.01% 260
2026
Q1
$38.6K Buy
+132
New +$43.4K 0.01% 305
2025
Q4
Sell
-132
Closed -$42.7K 232
2025
Q3
$42.7K Sell
132
-110
-45% -$34.2K 0.01% 275
2025
Q2
$94.1K Hold
242
0.03% 166
2025
Q1
$105K Buy
242
+27
+13% +$10.8K 0.04% 145
2024
Q4
$79.3K Sell
215
-27
-11% -$11.3K 0.03% 172
2024
Q3
$126K Sell
242
-38
-14% -$20.3K 0.05% 125
2024
Q2
$150K Sell
280
-267
-49% -$141K 0.06% 120
2024
Q1
$283K Buy
547
+347
+174% +$173K 0.12% 82
2023
Q4
$94.3K Buy
+200
New +$92.5K 0.03% 254

Other funds holding ELV

Main Street Group's ELV Position: Q2 2026 in Review

Main Street Group held its Elevance Health (ELV) position steady in Q2 2026 at 132 shares worth $51K. The position accounts for 0.01% of the portfolio, ranked #260.

Main Street Group first reported a position in ELV in Q4 2023 and has held it in 10 quarters since. The position peaked at $283K in Q1 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Main Street Group held 132 shares of Elevance Health worth $51K as of Q2 2026.
  • Main Street Group left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.01% of Main Street Group's portfolio in Q2 2026, its #260 holding.
  • Main Street Group first reported a position in Elevance Health in Q4 2023 and has held it in 10 quarters since.
  • Main Street Group's Elevance Health position peaked at $283K in Q1 2024.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.